DROTRECOGINUM ALFA

4-amino-N-[5-amino-4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-hydroxycyclohexyl]-2-hydroxybutanamide can be used in the treatment of sepsis, stroke, and acute thrombotic diseases with high mortality and/or morbidity.